1. Home
  2. CLDX vs SIMO Comparison

CLDX vs SIMO Comparison

Compare CLDX & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • SIMO
  • Stock Information
  • Founded
  • CLDX 1983
  • SIMO 1995
  • Country
  • CLDX United States
  • SIMO Hong Kong
  • Employees
  • CLDX N/A
  • SIMO N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SIMO Semiconductors
  • Sector
  • CLDX Health Care
  • SIMO Technology
  • Exchange
  • CLDX Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • CLDX 1.7B
  • SIMO 1.9B
  • IPO Year
  • CLDX 2008
  • SIMO 2005
  • Fundamental
  • Price
  • CLDX $20.14
  • SIMO $51.45
  • Analyst Decision
  • CLDX Buy
  • SIMO Strong Buy
  • Analyst Count
  • CLDX 7
  • SIMO 8
  • Target Price
  • CLDX $55.67
  • SIMO $80.63
  • AVG Volume (30 Days)
  • CLDX 714.4K
  • SIMO 459.3K
  • Earning Date
  • CLDX 05-05-2025
  • SIMO 05-01-2025
  • Dividend Yield
  • CLDX N/A
  • SIMO 3.89%
  • EPS Growth
  • CLDX N/A
  • SIMO 69.06
  • EPS
  • CLDX N/A
  • SIMO 2.68
  • Revenue
  • CLDX $7,020,000.00
  • SIMO $803,552,000.00
  • Revenue This Year
  • CLDX N/A
  • SIMO $2.80
  • Revenue Next Year
  • CLDX $27.01
  • SIMO $13.32
  • P/E Ratio
  • CLDX N/A
  • SIMO $19.44
  • Revenue Growth
  • CLDX 1.99
  • SIMO 25.72
  • 52 Week Low
  • CLDX $18.61
  • SIMO $48.81
  • 52 Week High
  • CLDX $47.00
  • SIMO $85.87
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 41.83
  • SIMO 42.01
  • Support Level
  • CLDX $18.95
  • SIMO $49.16
  • Resistance Level
  • CLDX $21.85
  • SIMO $54.69
  • Average True Range (ATR)
  • CLDX 1.39
  • SIMO 2.58
  • MACD
  • CLDX 0.08
  • SIMO -0.56
  • Stochastic Oscillator
  • CLDX 38.64
  • SIMO 24.08

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is active in the semiconductor industry and focuses on designing, developing, and marketing of controllers for managing NAND flash used in embedded storage applications, such as eMMC embedded memory. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: